DCTH Delcath stock news
On August 21, 2026, Delcath Systems Inc. (Nasdaq: DCTH) announced the activation of its 22nd commercial treatment center at the University of Chicago Medicine. This expansion enhances the company's geographic reach in the Midwestern United States and marks continued progress toward its stated goal of 30 active sites by the end of 2026. Additionally, management confirmed its participation in the Morgan Stanley Global Healthcare Conference on September 9, 2026, where it will provide an update on the commercial adoption of the HEPZATO KIT.